financetom
Business
financetom
/
Business
/
Copart Fiscal Q1 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Copart Fiscal Q1 Earnings, Revenue Rise
Nov 20, 2025 2:37 PM

04:21 PM EST, 11/20/2025 (MT Newswires) -- Copart ( CPRT ) reported fiscal Q1 earnings late Thursday of $0.41 per diluted share, up from $0.37 a year earlier.

Analysts surveyed by FactSet expected $0.39.

Revenue for the three months ended Oct. 31 was $1.16 billion, up from $1.15 billion a year earlier.

Analysts polled by FactSet expected $1.18 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Procter & Gamble's Fiscal Q2 Organic Growth Likely Muted, UBS Says
Procter & Gamble's Fiscal Q2 Organic Growth Likely Muted, UBS Says
Mar 11, 2026
11:27 AM EST, 01/16/2026 (MT Newswires) -- Procter & Gamble's ( PG ) fiscal Q2 organic growth is likely muted but could improve in H2 as the sector weathers retailer de-stocking and weaker demand, UBS Securities said in a Friday note. UBS said concerns over organic growth is not specific to the company and there are debates on whether its...
Kazakh oil exports via CPC pipeline drop 24% in December after drone attacks, source says
Kazakh oil exports via CPC pipeline drop 24% in December after drone attacks, source says
Mar 11, 2026
* December flows from CPC dropped to 3.98 million tonnes - source * The decline contrasts with rising 2025 exports of 12% * A November drone strikes severely damaged CPC export equipment * Kazakhstan diverted 300,000 tonnes of oil from CPC in December (Adds detail, background) MOSCOW, Jan 16 (Reuters) - Oil exports via the Caspian Pipeline ‌Consortium, which brings...
Arbutus Biopharma Says European Patent Office Revokes Patent; Shares Fall
Arbutus Biopharma Says European Patent Office Revokes Patent; Shares Fall
Mar 11, 2026
09:57 AM EST, 01/16/2026 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said in a regulatory filing Friday that the Board of Appeal of the European Patent Office verbally revoked the company's patent EP 2279254. The decision was made in connection with notices of opposition to the patent by affiliates of Moderna Therapeutics (MRNA) and Merck, Sharp & Dohme, Arbutus...
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal
Mar 11, 2026
Jan 16 (Reuters) - Institutional Shareholder Services on Friday recommended that ‌shareholders approve ​plans by Kleenex maker ‍Kimberly-Clark to ⁠buy ⁠Tylenol maker Kenvue ( KVUE ), ‌saying ​a tie-up could improve financial ⁠metrics. On ‍balance, ​support for the transaction is warranted, wrote ‍ISS, whose recommendations often guide how large ​investors vote ‍on hot button issues ​like mergers and who serves...
Copyright 2023-2026 - www.financetom.com All Rights Reserved